date:Apr 27, 2012
The report entitled,Abbott Laboratories Similac Stage 1; A first step towards malnutrition, caused a stir last month suggesting Abbotts product failed to reach Chinas safety standards, testing the worst among six brands.
Abbott Laboratories was quick to refute themisleadingreport it said was set up to deliberately damage its reputation. It threatened legal action in a series of letters submitted by Chinese lawyers representing the US-headquartered infant formula giant.
Court action followed in H